238 related articles for article (PubMed ID: 21645206)
1. Treatment of chronic hepatitis B virus infection in resource-constrained settings: expert panel consensus.
Wiersma ST; McMahon B; Pawlotsky JM; Thio CL; Thursz M; Lim SG; Ocama P; Esmat G; Mendy M; Bell D; Vitoria M; Eramova I; Lavanchy D; Dusheiko G;
Liver Int; 2011 Jul; 31(6):755-61. PubMed ID: 21645206
[TBL] [Abstract][Full Text] [Related]
2. Management of hepatitis B virus infection in the underprivileged world.
Almasio PL; Craxì A
Liver Int; 2011 Jul; 31(6):749-50. PubMed ID: 21645204
[No Abstract] [Full Text] [Related]
3. Chronic hepatitis B in Asia-new insights from the past decade.
Chan HL; Jia J
J Gastroenterol Hepatol; 2011 Jan; 26 Suppl 1():131-7. PubMed ID: 21199524
[TBL] [Abstract][Full Text] [Related]
4. Hepatitis B virus epidemiology, disease burden, treatment, and current and emerging prevention and control measures.
Lavanchy D
J Viral Hepat; 2004 Mar; 11(2):97-107. PubMed ID: 14996343
[TBL] [Abstract][Full Text] [Related]
5. Hepatitis B and human immunodeficiency virus co-infection.
Phung BC; Sogni P; Launay O
World J Gastroenterol; 2014 Dec; 20(46):17360-7. PubMed ID: 25516647
[TBL] [Abstract][Full Text] [Related]
6. Prevention of hepatocellular carcinoma in hepatitis B virus infection.
Lim SG; Mohammed R; Yuen MF; Kao JH
J Gastroenterol Hepatol; 2009 Aug; 24(8):1352-7. PubMed ID: 19702903
[TBL] [Abstract][Full Text] [Related]
7. Hepatitis C, a global issue: access to care and new therapeutic and preventive approaches in resource-constrained areas.
Lemoine M; Thursz M
Semin Liver Dis; 2014 Feb; 34(1):89-97. PubMed ID: 24782262
[TBL] [Abstract][Full Text] [Related]
8. The epidemiological changes of HCV and HBV infections in the era of new antiviral therapies and the anti-HBV vaccine.
Stasi C; Silvestri C; Voller F; Cipriani F
J Infect Public Health; 2016; 9(4):389-95. PubMed ID: 26148849
[TBL] [Abstract][Full Text] [Related]
9. Care of HIV patients with chronic hepatitis B: updated recommendations from the HIV-Hepatitis B Virus International Panel.
Soriano V; Puoti M; Peters M; Benhamou Y; Sulkowski M; Zoulim F; Mauss S; Rockstroh J
AIDS; 2008 Jul; 22(12):1399-410. PubMed ID: 18614862
[TBL] [Abstract][Full Text] [Related]
10. NIH consensus development statement on management of hepatitis B.
Belongia EA; Costa J; Gareen IF; Grem JL; Inadomi JM; Kern ER; McHugh JA; Petersen GM; Rein MF; Sorrell MF; Strader DB; Trotter HT
NIH Consens State Sci Statements; 2008 Oct 22-24; 25(2):1-29. PubMed ID: 18949020
[TBL] [Abstract][Full Text] [Related]
11. Estimating the future health burden of chronic hepatitis B and the impact of therapy in Spain.
Idris BI; Brosa M; Richardus JH; Esteban R; Schalm SW; Buti M
Eur J Gastroenterol Hepatol; 2008 Apr; 20(4):320-6. PubMed ID: 18334876
[TBL] [Abstract][Full Text] [Related]
12. Antiviral therapy for chronic hepatitis B: a review.
Hanazaki K
Curr Drug Targets Inflamm Allergy; 2004 Mar; 3(1):63-70. PubMed ID: 15032642
[TBL] [Abstract][Full Text] [Related]
13. How to improve access to therapy in hepatitis B patients.
Subic M; Zoulim F
Liver Int; 2018 Feb; 38 Suppl 1():115-121. PubMed ID: 29427482
[TBL] [Abstract][Full Text] [Related]
14. [Development of Markov models for economics evaluation of strategies on hepatitis B vaccination and population-based antiviral treatment in China].
Yang PC; Zhang SX; Sun PP; Cai YL; Lin Y; Zou YH
Zhonghua Liu Xing Bing Xue Za Zhi; 2017 Jul; 38(7):845-851. PubMed ID: 28738454
[No Abstract] [Full Text] [Related]
15. Challenges and priorities in the management of HIV/HBV and HIV/HCV coinfection in resource-limited settings.
Easterbrook P; Sands A; Harmanci H
Semin Liver Dis; 2012 May; 32(2):147-57. PubMed ID: 22760654
[TBL] [Abstract][Full Text] [Related]
16. Hepatitis B Vaccination, Screening, and Linkage to Care: Best Practice Advice From the American College of Physicians and the Centers for Disease Control and Prevention.
Abara WE; Qaseem A; Schillie S; McMahon BJ; Harris AM; ; Abraham GM; Centor R; DeLong DM; Gantzer HE; Horwitch CA; Humphrey LL; Jokela JA; Li JMW; Lohr RH; López AM; McLean RM
Ann Intern Med; 2017 Dec; 167(11):794-804. PubMed ID: 29159414
[TBL] [Abstract][Full Text] [Related]
17. Does antiviral therapy for hepatitis B and C prevent hepatocellular carcinoma?
Lok AS
J Gastroenterol Hepatol; 2011 Feb; 26(2):221-7. PubMed ID: 21070361
[TBL] [Abstract][Full Text] [Related]
18. A mathematical model to estimate global hepatitis B disease burden and vaccination impact.
Goldstein ST; Zhou F; Hadler SC; Bell BP; Mast EE; Margolis HS
Int J Epidemiol; 2005 Dec; 34(6):1329-39. PubMed ID: 16249217
[TBL] [Abstract][Full Text] [Related]
19. Treatment of hepatitis B and C in children.
El-Shabrawi M; Hassanin F
Minerva Pediatr; 2014 Oct; 66(5):473-89. PubMed ID: 25253190
[TBL] [Abstract][Full Text] [Related]
20. A Global View to HBV Chronic Infection: Evolving Strategies for Diagnosis, Treatment and Prevention in Immunocompetent Individuals.
Nicolini LA; Orsi A; Tatarelli P; Viscoli C; Icardi G; Sticchi L
Int J Environ Res Public Health; 2019 Sep; 16(18):. PubMed ID: 31505743
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
